On May 31st, 2019, Consumer Choice Center Deputy Director Yaël Ossowski was invited to provide testimony to the U.S. Food and Drug Administration on regulations for cannabis and cannabis-derived compounds such as CBD.
On May 31st, 2019, Consumer Choice Center Deputy Director Yaël Ossowski was invited to provide testimony to the U.S. Food and Drug Administration on regulations for cannabis and cannabis-derived compounds such as CBD.